Silco Pharmaceuticals Limited (DSE:SILCOPHL)
Bangladesh · Delayed Price · Currency is BDT 14.40
-0.10 (-0.69%)
At close: Jan 22, 2026
Silco Pharmaceuticals Market Cap
Silco Pharmaceuticals has a market cap or net worth of 1.49 billion as of January 23, 2026. Its market cap has decreased by -13.25% in one year.
Market Cap
1.49B
Enterprise Value
1.48B
Revenue
428.63M
Ranking
n/a
PE Ratio
31.90
Stock Price
14.40
Market Cap Chart
Since June 13, 2019, Silco Pharmaceuticals's market cap has decreased from 2.37B to 1.49B, a decrease of -36.89%. That is a compound annual growth rate of -6.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 1.49B | 6.67% |
| Dec 30, 2025 | 1.40B | -15.09% |
| Dec 30, 2024 | 1.65B | -32.05% |
| Dec 28, 2023 | 2.43B | - |
| Dec 29, 2022 | 2.43B | -2.90% |
| Dec 30, 2021 | 2.50B | 0.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Asiatic Laboratories | 6.56B |
| Orion Pharma | 6.48B |
| Navana Pharmaceuticals | 5.74B |
| Techno Drugs | 4.18B |
| Ambee Pharmaceuticals | 1.69B |
| Pharma Aids | 1.56B |
| Indo-Bangla Pharmaceuticals | 1.45B |
| Libra Infusions | 1.42B |